Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Adaptive Biotechnologies at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Adaptive Biotechnologies brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3629. Its research centres on measuring residual disease in lymphoma. It covers validating the clonoSEQ test on cell-free DNA for large B-cell lymphoma.

OrganizationASH 2026 Attendance
Diagnostics
Immune-sequencing company behind the clonoSEQ minimal residual disease test; also develops immune-based diagnostics and therapeutics.
Booth
Exhibiting at Booth 3629
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Adaptive Biotechnologies

Tell us what you sell and we’ll find the people at Adaptive Biotechnologies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction